FDA 'Entrepreneurs-In-Residence' Program Aims To Help Small Companies
This article was originally published in The Gray Sheet
Executive Summary
New FDA measures aimed at helping small businesses navigate the regulatory review process are part of the agency’s larger counter-attack against claims that it is creating a drag on medical product innovation.
You may also be interested in...
FDA Commish Hamburg Gets Fond Farewell
FDA Commissioner Margaret Hamburg said she will step down from the agency after six years in the post. She is being widely praised by lawmakers and industry as an effective bureaucrat who has worked to improve FDA’s regulatory processes and speed the path to market for new products.
Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program
CDRH is hoping to inject a dose of start-up-firm mentality into its processes with the official launch last week of the entrepreneurs-in-residence pilot program as part of a broader FDA push to highlight its “innovation” bona fides.
Start-Up FDA? CDRH Seeks Entrepreneurial Spirit With New “In-Residence” Program
CDRH is hoping to inject a dose of start-up-firm mentality into its processes with the official launch last week of the entrepreneurs-in-residence pilot program as part of a broader FDA push to highlight its “innovation” bona fides.